Pfizer COVID-19 vaccine study to include kids as young as 12
Oct 15 2020
"To ensure we can find a safe and effective vaccine that works for everyone, we all need to get involved".
"We are extending and expanding our fast-track approach to address the COVID emergency so that developing countries have fair and equal access to vaccines", said World Bank Group President David Malpass.
Sources said, meanwhile, the phase-3 trial of Sputnik V is underway in Russian Federation since September 1 on around 40,000 subjects. "We are continuing to cooperate with our foreign partners and will promote our vaccine overseas".
Pfizer's trial also includes significant numbers of Hispanic, Black, Asian and Native American participants, plus many people aged 56 through 85.
Russia's sovereign wealth fund, is supported by the UAE's leading laboratory provider PureHealth, on the UAE trials of the Sputnik V vaccine, which was developed by the Gamaleya National Research Institute of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation. She also said that 40,000 volunteers will participate in a third-phase clinical trial, including people over 65 years-old.
The trial is expected to involve 30,000 volunteers, of whom the first 5,000 will be residents of Siberia, according to the Interfax news agency.
Black, Asian and minority ethnic groups are underrepresented in trials and disproportionately affected by the coronavirus, with figures from Public Health England showing that black people are more likely to be diagnosed with COVID-19.
On Tuesday, the Russian anti-coronavirus crisis center confirmed 13,868 new coronavirus cases, setting a record for new infections since the start of the pandemic as authorities at the epicenter of the outbreak consider new restrictions to slow the spread of the disease.
The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc PFE.N and Germany's BioNTech 22UAy.F , with delivery potentially as early as the first quarter of 2021.
Around 270,000 volunteers are now taking part in testing for the UK Vaccine Taskforce but those from ethnic minority groups, including the Jewish community, are under-represented - along with those with chronic diseases and the over 65s.